Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

Mayass El Ayoubi; Pierre Henri Jarreau; Patrick Van Reempts; Marina Cuttini; Monique Kaminski; Jennifer Zeitlin

doi:10.3109/14767058.2015.1012062

Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

Mayass El Ayoubi, Pierre Henri Jarreau, Patrick Van Reempts, Marina Cuttini, Monique Kaminski, Jennifer Zeitlin

Ospedale Pediatrico Bambino Gesu

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

Original language	English
Pages (from-to)	596-601
Number of pages	6
Journal	Journal of Maternal-Fetal and Neonatal Medicine
Volume	29
Issue number	4
DOIs	https://doi.org/10.3109/14767058.2015.1012062
Publication status	Published - Feb 16 2016

Keywords

Birthweight percentile
bronchopulmonary dysplasia
fetal growth restriction
in-hospital mortality
preterm infants
severe neurological morbidity

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Obstetrics and Gynaecology

Access to Document

10.3109/14767058.2015.1012062

Cite this

El Ayoubi, M., Jarreau, P. H., Van Reempts, P., Cuttini, M., Kaminski, M., & Zeitlin, J. (2016). Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. Journal of Maternal-Fetal and Neonatal Medicine, 29(4), 596-601. https://doi.org/10.3109/14767058.2015.1012062

Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort. / El Ayoubi, Mayass; Jarreau, Pierre Henri; Van Reempts, Patrick et al.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 29, No. 4, 16.02.2016, p. 596-601.

Research output: Contribution to journal › Article › peer-review

El Ayoubi, M, Jarreau, PH, Van Reempts, P, Cuttini, M, Kaminski, M & Zeitlin, J 2016, 'Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort', Journal of Maternal-Fetal and Neonatal Medicine, vol. 29, no. 4, pp. 596-601. https://doi.org/10.3109/14767058.2015.1012062

@article{4569d177b0104a3688f02c104cac34f0,

title = "Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort",

abstract = "Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles ",

keywords = "Birthweight percentile, bronchopulmonary dysplasia, fetal growth restriction, in-hospital mortality, preterm infants, severe neurological morbidity",

author = "{El Ayoubi}, Mayass and Jarreau, {Pierre Henri} and {Van Reempts}, Patrick and Marina Cuttini and Monique Kaminski and Jennifer Zeitlin",

year = "2016",

month = feb,

day = "16",

doi = "10.3109/14767058.2015.1012062",

language = "English",

volume = "29",

pages = "596--601",

journal = "Journal of Maternal-Fetal and Neonatal Medicine",

issn = "1476-7058",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

AU - El Ayoubi, Mayass

AU - Jarreau, Pierre Henri

AU - Van Reempts, Patrick

AU - Cuttini, Marina

AU - Kaminski, Monique

AU - Zeitlin, Jennifer

PY - 2016/2/16

Y1 - 2016/2/16

N2 - Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

AB - Objective: We investigated the impact of antenatal diagnosis of fetal growth restriction (FGR) on the risks of mortality and morbidity for very preterm infants given actual birthweight percentiles.Methods: Data on 4608 live born infants 24-31 weeks of gestational age (GA) in 10 European regions in 2003 were used to compare in-hospital mortality, bronchopulmonary dysplasia (BPD) and severe neurological morbidity by birthweight percentiles and antenatal diagnosis of FGR. Other covariates were GA, sex, multiplicity, maternal complications, antenatal corticosteroids, birth in a level III center and region.Results: Sixteen percent (n = 728) of all infants and 72%, 30% and 6%, respectively, of those with birthweight percentiles

KW - Birthweight percentile

KW - bronchopulmonary dysplasia

KW - fetal growth restriction

KW - in-hospital mortality

KW - preterm infants

KW - severe neurological morbidity

UR - http://www.scopus.com/inward/record.url?scp=84950341729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950341729&partnerID=8YFLogxK

U2 - 10.3109/14767058.2015.1012062

DO - 10.3109/14767058.2015.1012062

M3 - Article

C2 - 25747950

AN - SCOPUS:84950341729

VL - 29

SP - 596

EP - 601

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 4

ER -

Does the antenatal detection of fetal growth restriction (FGR) have a prognostic value for mortality and short-term morbidity for very preterm infants? Results from the MOSAIC cohort

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this